VarmusH.Shattuck lecture-biomedical research enters the steady state. N Engl J Med1995;333:811–5.
2.
MatherleeKR.The outlook for clinical research-impacts of feder-al funding restraint and private sector reconfiguration. Acad Med1995;70:1065–72.
3.
SteinbergEP, TunisS, ShapiroD.Insurance coverage for experi-mental technologies. Health Aff (Millwood)1995;14:143–58.
4.
SteinerCA, PoweNR, AndersonGF, DasA.The review process used by U.S. health care plans to evaluate new medical technology for coverage. J Gen Intern Med1996;11:294–302.
5.
KennedyWR, NavarroX, GoetzFC, SutherlandDER, NajarianJS.Effects of transplantation on diabetic neuropathy. N Engl J Med1990;322:1031–7.
6.
CheungAH, SutherlandDER, GillinghamKJ, McHughLE, Moudry-MunnsKC, DunnDL, NajarianJS, MatasAJ.Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. Kidney Int1992;41:992–4.
7.
ManskeCL, WangY, ThomasW.Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in dia-betic patients. Lancet1995;346:1658–62.
HunsickerLG.Renal transplantation for the nephrologist: is pan-creas transplantation for diabetic ESRD now accepted therapy?Am J Kidney Dis1990;15:93–6.
10.
PykeDA.A critique of pancreas transplantation. Clin Transplant1990;4:235–7.
11.
RemuzziG, RuggenentiP, MauerSM.Pancreas and kidney/pan-creas transplants: experimental medicine or real improvement?Lancet1994;343:27–31.
12.
MahaneyFX.Bone marrow transplant for breast cancer: some insurers pay, some insurers don't. J Natl Cancer Inst1994;86:420–1.
13.
BunkerJP, FowlesJ, SchaffarzickR.Evaluation of medical-technology strategies: proposal for an institute for health care evaluation. N Engl J Med1982;306:687–92.
14.
HarkinT, HatfieldMO.A compelling case for a trust fund for medical research. Clin Res1993;41:603–4.
15.
AntmanKH, AledortLM, YarbroJ, WilenskyG, WojcikS, MonacoGP, WindhamS.Cost-effectiveness and reimbursement in patient care. Semin Hematol1989;26(3 Suppl):32–45.
